Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
Amount Raised
$75 Million
Round Type
Funding Round
ClevelandBiotechnologyFinancial ServicesHealth CareMedicalHealth DiagnosticsInvestors
Description
Cleveland Diagnostics, Inc. announced the closing of over $75M in growth capital financing led by Novo Holdings, with participation from existing investors as well as a credit facility from Symbiotic Capital. The financing will accelerate Cleveland Diagnostics’ commercial and corporate development goals in 2024.
Who to call at Cleveland Diagnostics, and when
A new round usually means Cleveland Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cleveland Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cleveland Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cleveland Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cleveland Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cleveland Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.